The First And Only FDA-Approved EAI For Infants, Toddlers To Be Launched In May

The first and only FDA-approved epinephrine auto-injector for treating anaphylaxis in infants and small children, AUVI-q 0.1 mg, developed by privately-held kaléo, will hit the U.S. pharmacy shelves beginning May 1, 2018.

from RTT - Biotech https://ift.tt/2JyOxmd
via IFTTT